Global Flow Cytometry Market, By Technology (Cell-based flow cytometry, Bead-based flow cytometry), By Products and Services (Reagents and consumables, Instruments, Services, Software, Accessories), By Applications (Research applications, Clinical applications, Industrial applications), By End User (Academic & research institutes, Hospitals & clinical testing laboratories, Pharmaceutical & biotechnology companies), By Region (North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, Rest of the World) – Market Size & Forecasting(2016-2025)

The worldwide flow cytometry industry is increasing at a good rate and is likely to guarantee elevated development in the coming years. Increasing investments for research and development operations by the major firms are likely to accelerate the general market development in the coming years. In addition, the increase in the number of apps and the increase in disease prevalence are expected to guarantee general market growth in the coming years.

It is expected that a significant increase in the implementation of flow cytometry methods in clinical trials and study activities will encourage the development of the worldwide flow cytometry industry in the coming years. It is expected that the growing incidence of cancer and HIV / AIDS and technological advances will attract a big amount of players, thereby improving market growth in the near future. In relation to this, it is estimated that the increasing accessibility of new application-specific flow cytometry goods and increasing stem cell research will sustain market growth in the near future.

Due to increased healthcare spending and improvisation in healthcare services, the biotechnology sector is anticipated to show important development in the coming years. Growing external financing for clinical studies in the field of molecular diagnosis in vitro is also anticipated to increase the market, as these projects play a crucial part in the growth of fresh products.

Key Factors Impacting Market Growth:

  • Advances in technology

  • Rising adoption in research and academia of flow cytometry techniques

  • Increasing public-private immunology and immuno-oncology initiatives

Key Developments:

  • BD FACSymphony S6 High Parameter Cell Sorter was introduced by Becton, Dickinson, and Company (US) in 2018.

  • Agilent Technologies, Inc. (US) signed an agreement in 2018 to purchase ACEA Biosciences Inc. (US) to expand its worldwide income base, product portfolio and reinforce its market share.

  • In 2018 the CellStream benchtop flow cytometer system was introduced by Merck KGaA (Germany).

Regional Analysis:

North America, Western Europe, and the Asia Pacific by region are estimated to dominate the flow cytometry market during the forecast period. These regions have been market leaders for the overall healthcare sector in terms of technological developments and advanced medical treatments. Moreover, the government policies have been favorable for the growth of the healthcare infrastructure in these regions. North America and Western Europe have an established healthcare infrastructure for product innovations and early adaptations. This is expected to drive the demand for the flow cytometry market during the forecast period. The US, Germany, France, UK, Canada, and Spain have been some of the major markets in the region.

Asia Pacific is estimated to register one of the highest CAGR for the flow cytometry market during the forecast period. This region has witnessed strategic investments by global companies to cater to the growing demand in recent years. China, Japan, India, South Korea, and Australia are amongst some of the key countries for the flow cytometry market in the region. Other regions including the Middle East, Eastern Europe, and Rest of the World (South America and Africa) are estimated to be emerging markets for the flow cytometry during the forecast period.

Companies Covered: Becton, Dickinson and Company, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Merck KGaA, Sysmex Partec GmbH, Luminex Corporation, Miltenyi Biotec GmbH, Bio-Rad Laboratories, Inc., Sony Biotechnology, Inc., Agilent Technologies, Inc., bioMérieux S.A., Enzo Life Sciences, Inc., Stratedigm, Inc., Cytonome/ST LLC and Apogee Flow Systems Ltd…

Market Segmentation:

By Technology:

  • Cell-based flow cytometry

  • Bead-based flow cytometry

By Products and Services:

  • Reagents and consumables

  • Instruments

    • Cell analyzers

    • Cell sorters

  • Services

  • Software

  • Accessories

By Applications:

  • Research applications

    • Pharmaceutical and biotechnology

    • Immunology

    • Cell sorting

    • Apoptosis

    • Cell cycle analysis

    • Cell viability

    • Cell counting

    • Other research applications

  • Clinical applications

    • Cancer

    • Hematology

    • Immunodeficiency diseases

    • Organ transplantation

    • Other clinical applications

  • Industrial applications

By End User:

  • Academic & research institutes

  • Hospitals & clinical testing laboratories

  • Pharmaceutical & biotechnology companies

By Region:

  • North America

    • By Country (US, Canada, Mexico)

    • By Technology

    • By Products and Services

    • By Applications

    • By End Users

  • Western Europe

    • By Country (Germany, UK, France, Spain, Rest of Western Europe)

    • By Technology

    • By Products and Services

    • By Applications

    • By End Users

  • Eastern Europe

    • By Country (Russia, Turkey, Rest of Eastern Europe)

    • By Technology

    • By Products and Services

    • By Applications

    • By End Users

  • Asia Pacific

    • By Country (China, Japan, India, Rest of Asia Pacific)

    • By Technology

    • By Products and Services

    • By Applications

    • By End Users

  • Middle East

    • By Country (UAE, Qatar, Iran, Saudi Arabia, Rest of Middle East)

    • By Technology

    • By Products and Services

    • By Applications

    • By End Users

  • Rest of the World

    • By Region (South America, Africa)

    • By Technology

    • By Products and Services

    • By Applications

    • By End Users

Reasons To Buy This Report:

  • Market size estimation of the flow cytometry market on a regional and global basis

  • Unique research design for market size estimation and forecast

  • Profiling of major companies operating in the market with key developments

  • Broad scope to cover all the possible segments helping every stakeholder in the market

Customization:

We provide customization of the study to meet specific requirements:

  • By Segment

  • By Sub-segment

  • By Region/Country

For more information, contact: sales@quincemarketinsights.com